Clinical Study
Gestational Diabetes and Thyroid Autoimmunity
Table 1
Clinical characteristics and laboratory data of the four groups of women evaluated.
| | Groups | A1 () | A2 () | B1 () | B2 () |
| Mean age (years) | | | | | Time from delivery (range, months) | — | — | 18–120 | 18–96 | BMI at OGTT | | | | — | BMI at follow-up | — | — | | | GAD65-Ab positivity [n (%)] | 3 (3.3) | 0 | 2 (5.3) | 0 | Mean FT4 (ng/dL) | | | | | Mean TSH (mIU/L) | | | | | TSH < 0.4 mIU/L [n (%)] | 8 (8.8) | 2 (5.7) | 5 (13.1) | 2 (6.5) | TSH > 4.2 mIU/L [n (%)] | 2 (2.2) | 2 (5.7) | 4 (10.5) | 1 (3.2) | Overall abnormal TSH [n (%)] | 10 (11.0) | 4 (11.4) | 9 (23.7)* | 3 (9.7) | Thyroid Ab positivity [n (%)] | 16 (17.6) | 5 (14.4) | 12 (31.6)* | 3 (9.7) | Abnormal TSH + thyroid Ab positivity [n (%)] | 3 (3.3) | 0 (−) | 7 (18.4)** | 1 (3.2) |
|
|
versus groups A1 and B2; versus groups B2 and versus group A1. Where indicated, data are means ± SD.
|